http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cb769db6ae10f64e40466bfada15414
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hall |
| name | Ian P. Hall Ian P Hall |
| given-name | Ian P Ian P. |
| organization-name | From the Divisions of Epidemiology and Public Health (J.W.D., T.M.M., R.B.H., A.W.F.) and Therapeutics and Molecular Medicine (I.P.H.), University of Nottingham, UK. Division of Respiratory Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK. Electronic address: ian.hall@nottingham.ac.uk. Department of Clinical Pharmacology and Therapeutics, and Department of Physiology and Biochemistry, University of Malta, Msida, Malta; and Division of Therapeutics, University of Nottingham, Nottingham, United Kingdom Division of Respiratory Medicine NIHR Nottingham Biomedical Research Centre, University of Nottingham Nottingham UK Department of Medicine, University Hospital, Queen’s Medical Center, Nottingham N67 2UH, United Kingdom Division of Therapeutics and Molecular Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom Division of Respiratory Medicine, University Hospital of Nottingham, Nottingham, UK. Division of Therapeutics and Molecular Medicine, Nottingham Respiratory Biomedical Research Unit, University Hospital of Nottingham, Nottingham, United Kingdom Division of Respiratory Medicine, University of Nottingham, Queen’s Medical Centre, Nottingham, United Kingdom; and Division of Therapeutics and Molecular Medicine, Nottingham Respiratory Biomedical Research Unit, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom Division of Therapeutics & Institute of Cell Signalling, and Public Health Laboratory, University Hospital of Nottingham, Nottingham, United Kingdom; and Departments of Medicine, Division of Critical Care, Pulmonary, Allergic, and Immunological Diseases, and Microbiology & Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania Division of Therapeutics and Molecular Medicine University of Nottingham Nottingham NG7 2UH UK Department of Therapeutics and Molecular Medicine NIHR Nottingham Biomedical Research Centre Nottingham UK Division of Respiratory Medicine, Queen’s Medical Centre, University of Nottingham, Nottingham, United Kingdom Department of Therapeutics, Institute of Cell Signaling, University Hospital of Nottingham, Nottingham, United Kingdom NG7 2UH; Department of Therapeutics, University Hospital, Queen's Medical Centre, Nottingham, U.K. Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, U.K. Nottingham Respiratory Research Unit and Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK Division of Therapeutics, University Hospital Division of Therapeutics, University Hospital, Queens Medical Centre, Nottingham; and Novartis Respiratory Research Centre, Wimblehurst Road, Horsham, United Kingdom Department of Therapeutics, Institute of Cell Signaling, University Hospital of Nottingham, Nottingham NG7 2UH, United Kingdom Department of Therapeutics, Institute of Cell Signalling, University Hospital of Nottingham, Nottingham, United Kingdom; Division of Pulmonary and Critical Care, Department of Medicine, University of Pennsylvania School of Medicine; and Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania National Institute for Health Research Nottingham Biomedical Research Centre Respiratory Theme, School of Medicine, University of Nottingham, Nottingham, UK; Respiratory Medicine, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK Division of Respiratory Medicine National Institute for Health ResearchNottingham Biomedical Research CentreBiodiscovery InstituteUniversity of Nottingham Nottingham UK Division of Therapeutics, University Hospital, Nottingham, NG7 2UH, UK From the School of Medical and Surgical Sciences, Division of Therapeutics, and the Research Centre for Human and Clinical Sciences (J.P.N.), University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK. Division of Therapeutics, University Hospital, Nottingham NG7 2UH, United Kingdom Division of Therapeutics and Molecular Biology, University of Nottingham, Queens Medical Centre, Nottingham, United Kingdom; Division of Critical Care, Pulmonary, Allergic and Immunologic Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania; and Wake Forest University Health Science Center, Center for Human Genomics, Winston-Salem, North Carolina Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham NG7 2UH, United Kingdom Division of Therapeutics and Institute of Cell Signalling, University Hospital, Nottingham, United Kingdom Division of Respiratory Medicine; The University of Nottingham; Nottingham United Kingdom Division of Respiratory Medicine, University of Nottingham, Nottingham, NG7 2RD, UK. Ian.hall@nottingham.ac.uk. NIHR Nottingham Biomedical Research Centre, Queen’s Medical Centre, Nottingham, United Kingdom. Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland; Department of Pharmacology, University of Liverpool; Division of Therapeutics and Molecular Medicine, University of Nottingham; Department of Medicine, Queen's University of Belfast, United Kingdom; Department of Neurology and Neuroscience, Boston University, Boston, Massachusetts; Department of Dermatology, University of Utah, Salt Lake City, Utah; and Department of Clinical Pharmacology, University of... Department of Respiratory Medicine, University of Nottingham, Queens Medical Centre, Nottingham, UK. ian.hall@nottingham.ac.uk. National Jewish Health, Denver, Colorado Division of Therapeutics Queens Medical Center Nottingham, United Kingdom Department of Therapeutics, University Hospital of Nottingham, Nottingham, United Kingdom |
Incoming Links
Total number of triples: 209.